Skip to content
healthcare.dev

OTARMENI

NDC 61755-062, lunsotogene parvec-cwha, injection, solution, from Regeneron Pharmaceuticals, Inc..

Product NDC
61755-062
Status
Listed
Labeler
Regeneron Pharmaceuticals, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRACOCHLEAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125874
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61755-062 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LUNSOTOGENE PARVEC30000000000000 {GC}/mL
Package NDCNDC-11Package
61755-062-99617550062991 CARTON in 1 BAG (61755-062-99) / 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-062-01) / 1 mL in 1 VIAL, SINGLE-DOSE (61755-062-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a7a5e936-ab4a-4609-ac10-96efedc89035

Use it

Look up 61755-062 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61755-062 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61755-062. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.